TAKE A LOOK AT WHICH REPORT YOUR PORTFOLIO'S BEEN MISSING...

Shareholders Foundation offers real-time reporting of class action exposure on a per transaction basis,
including the documents you will need for claim filing and settlement recovery.
Start Monitoring Your Investments

Eagle Pharmaceuticals Inc (NASDAQ: EGRX) Investor Securities Class Action Lawsuit 05/31/2016

  • If you purchased shares of Eagle Pharmaceuticals Inc (NASDAQ: EGRX), you might have certain options and should contact the Shareholders Foundation, Inc.

  • To have your information reviewed for options and to receive notifications about this case, please send an email to mail@shareholdersfoundation.com, or call us at (858) 779-1554.

Lawsuit Overview

August 31, 2017 - The lead plaintiffs filed a notice of appeal. May 19, 2017 - The court granted defendants' motion to dismiss and dismissed the case without prejudice. December 16, 2016 - Defendants filed a motion to dismiss. October 31, 2016 - The lead plaintiffs filed an amended complaint. September 9, 2016 - Lead plaintiffs and lead counsel were appointed. August 1, 2016 - L...



You must register (for free) or login to view the entire case.

Click here to Sign In or Register (for a free account)

@screen width:
@theme:
@breakpoints:
@layout: